Nuvation Bio, Inc. (NUVB)
3.99
-0.07
(-1.72%)
USD |
NYSE |
Nov 13, 16:00
3.98
-0.01
(-0.25%)
Pre-Market: 19:59
Nuvation Bio Price to Book Value : 6.177 for Nov. 13, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 13, 2026 | 6.177 |
| November 12, 2026 | 6.285 |
| November 11, 2026 | 6.641 |
| November 10, 2026 | 6.502 |
| November 09, 2026 | 6.734 |
| November 06, 2026 | 6.44 |
| November 05, 2026 | 6.486 |
| November 04, 2026 | 7.322 |
| November 03, 2026 | 7.260 |
| November 02, 2026 | 7.106 |
| October 30, 2026 | 7.369 |
| October 29, 2026 | 7.384 |
| October 28, 2026 | 7.106 |
| October 27, 2026 | 7.044 |
| October 26, 2026 | 6.982 |
| October 23, 2026 | 7.075 |
| October 22, 2026 | 7.276 |
| October 21, 2026 | 7.508 |
| October 20, 2026 | 7.384 |
| October 19, 2026 | 6.935 |
| October 16, 2026 | 6.889 |
| October 15, 2026 | 7.353 |
| October 14, 2026 | 7.245 |
| October 13, 2026 | 7.307 |
| October 12, 2026 | 7.586 |
| Date | Value |
|---|---|
| October 09, 2026 | 7.740 |
| October 08, 2026 | 7.663 |
| October 07, 2026 | 7.524 |
| October 06, 2026 | 7.555 |
| October 05, 2026 | 7.663 |
| October 02, 2026 | 7.957 |
| October 01, 2026 | 8.607 |
| September 30, 2026 | 8.669 |
| September 29, 2026 | 7.744 |
| September 28, 2026 | 7.717 |
| September 25, 2026 | 7.910 |
| September 24, 2026 | 7.896 |
| September 23, 2026 | 7.868 |
| September 22, 2026 | 8.406 |
| September 21, 2026 | 8.364 |
| September 18, 2026 | 8.061 |
| September 17, 2026 | 8.364 |
| September 16, 2026 | 7.965 |
| September 15, 2026 | 7.992 |
| September 14, 2026 | 8.185 |
| September 11, 2026 | 8.364 |
| September 10, 2026 | 8.654 |
| September 09, 2026 | 8.985 |
| September 08, 2026 | 9.109 |
| September 04, 2026 | 9.384 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Pfizer Inc. | 1.850 |
| Johnson & Johnson | 8.437 |
| Merck & Co., Inc. | 8.119 |
| Bristol Myers Squibb Co. | 5.540 |
| ANI Pharmaceuticals, Inc. | 2.568 |
Price to Book Value Related Metrics
| PS Ratio | 7.034 |
| Price | 3.99 |
| Earnings Yield | -9.81% |
| Market Cap | 1.408B |